Acorda Therapeutics completes sales foce expansion

Share this article:
Acorda Therapeutics has completed the expansion of its sales force to 65 people, with 52 area business managers, calling on specialists and primary care physicians. The sales team promotes Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.